VIVAS slams EU decision to 'support subsidisation' of Vhi

VIVAS Health has expressed disappointment at the decision byt the European Court of First Instance to dismiss Bupa's challenge of risk equalisation in Ireland.

Chief executive of VIVAS Health Oliver Tattan said: "While we are disappointed that the Commission has endorsed a system of subsidisation of the most dominant player in the market and has deemed that this form of state aid is legal the CFI case was just one of many legal investigations underway at a local and European level.